Amal Therapeutics Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
29
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$367M
- Investors
-
1
Amal Therapeutics General Information
Description
Developer of therapeutic vaccines designed to facilitate oncology treatment. The company's peptide-based vaccines generate a cellular immune response including activation of killer T cells specific for the tumor cells and promote immunological memory necessary for a long-lasting anti-tumor immune response, enabling medical practitioners to treat cancer patients with ease and efficacy.
Contact Information
Website
www.amaltherapeutics.com(Operating Subsidiary)
Corporate Office
- C/o Fondation pour Recherches Médicales
- 64 avenue de la Roseraie
- 1205 Geneva
- Switzerland
Corporate Office
- C/o Fondation pour Recherches Médicales
- 64 avenue de la Roseraie
- 1205 Geneva
- Switzerland
Amal Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 15-Jul-2019 | $367M | Completed | Pre-Clinical Trials | ||
| 10. Early Stage VC (Series B) | 12-Nov-2018 | Completed | Pre-Clinical Trials | |||
| 9. Early Stage VC (Series A) | 30-Mar-2016 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 08-Mar-2016 | Completed | Startup | |||
| 7. Grant | 24-Jul-2014 | Completed | Startup | |||
| 6. Seed Round | 01-Feb-2014 | Completed | Startup | |||
| 5. Debt - General | 05-Aug-2013 | Completed | Startup | |||
| 4. Grant | 01-May-2013 | Completed | Startup | |||
| 3. Grant | 16-May-2012 | $21.7K | Completed | Startup | ||
| 2. Accelerator/Incubator | Completed | Startup |
Amal Therapeutics Comparisons
Industry
Financing
Details
Amal Therapeutics Competitors (112)
One of Amal Therapeutics’s 112 competitors is Immunophotonics, a Private Equity-Backed company based in Saint Louis, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunophotonics | Private Equity-Backed | Saint Louis, MO | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Arnatar Therapeutics | Venture Capital-Backed | San Diego, CA | ||||
| Immunitas Therapeutics | Formerly VC-backed | Boston, MA |
Amal Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amal Therapeutics Patents
Amal Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240033336-A1 | Tumor antigens, compounds comprising the tumor antigens and uses thereof | Pending | 16-Mar-2022 | ||
| US-20220111028-A1 | Combination of a sting agonist and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist | Inactive | 14-Oct-2020 | ||
| AU-2017331949-A1 | Fusion comprising a cell penetrating peptide, a multi epitope and a tlr peptide agonist for treatment of cancer | Active | 21-Sep-2016 | ||
| AU-2017331949-B2 | Fusion comprising a cell penetrating peptide, a multi epitope and a tlr peptide agonist for treatment of cancer | Active | 21-Sep-2016 | ||
| CA-3031170-A1 | Fusion comprising a cell penetrating peptide, a multi epitope and a tlr peptide agonist for treatment of cancer | Pending | 21-Sep-2016 | A61K40/34 |
Amal Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amal Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3B Future Health Fund | Venture Capital | Minority | ||
| BioMedPartners | Venture Capital | Minority | ||
| Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | ||
| Eurostars | Other | Minority | ||
| High-Tech Gründerfonds | Venture Capital | Minority |
Amal Therapeutics FAQs
-
When was Amal Therapeutics founded?
Amal Therapeutics was founded in 2012.
-
Where is Amal Therapeutics headquartered?
Amal Therapeutics is headquartered in Geneva, Switzerland.
-
What is the size of Amal Therapeutics?
Amal Therapeutics has 29 total employees.
-
What industry is Amal Therapeutics in?
Amal Therapeutics’s primary industry is Drug Discovery.
-
Is Amal Therapeutics a private or public company?
Amal Therapeutics is a Private company.
-
What is the current valuation of Amal Therapeutics?
The current valuation of Amal Therapeutics is .
-
What is Amal Therapeutics’s current revenue?
The current revenue for Amal Therapeutics is .
-
How much funding has Amal Therapeutics raised over time?
Amal Therapeutics has raised $36.4M.
-
Who are Amal Therapeutics’s investors?
3B Future Health Fund, BioMedPartners, Boehringer Ingelheim Venture Fund, Eurostars, and High-Tech Gründerfonds are 5 of 10 investors who have invested in Amal Therapeutics.
-
Who are Amal Therapeutics’s competitors?
Immunophotonics, Meditope Biosciences, Aro Biotherapeutics, Arnatar Therapeutics, and Immunitas Therapeutics are some of the 112 competitors of Amal Therapeutics.
-
When was Amal Therapeutics acquired?
Amal Therapeutics was acquired on 15-Jul-2019.
-
Who acquired Amal Therapeutics?
Amal Therapeutics was acquired by Boehringer Ingelheim.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
